Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesMental Diseases and DisordersDRG 883-disorders-of-personality-and-impulse-control
    Ask Trek AI about this page

    Disorders of Personality and Impulse Control: Inpatient Reimbursement Overview

    DRG 883 addresses inpatient hospitalizations for disorders of personality and impulse control, encompassing diagnoses that affect behavior regulation and social functioning and may require crisis or stabilization care. Accurate assignment of this Diagnosis-Related Group matters for inpatient reimbursement because Centers for Medicare & Medicaid Services payment hinges on the coded clinical complexity, documented severity, and presence of complications or comorbidities.

    Customize your policy alerts

    Sign up for drg 883 policy alerts

    Get alerted when payer policies referencing 883 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 883 Overview

    DRG 883 covers inpatient admissions primarily for disorders of personality and impulse control, including pervasive patterns of behavior that impair social and occupational functioning and acute presentations requiring stabilization. This Diagnosis-Related Group captures psychiatric interventions, observation, and resource use specific to personality and impulse control pathology during a hospital stay. It matters for Medicare payment because the Diagnosis-Related Group determines base reimbursement tied to documented diagnoses, length of stay, and any documented complications or comorbidities that affect resource utilization. Proper assignment of principal and secondary diagnoses influences payment under Centers for Medicare & Medicaid Services rules.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    National Payment Rates

    Across commercial payers the DRG rates range from as low as $370 (BCBS minimum) up to $52K (Cigna maximum), with mean payer payments spanning roughly $6K to $27K. The widest spread between payer minimums and maximums appears in the Cigna–Aetna–Cigna group, showing significant variability across commercial contracts; see the table and chart below for payer-level detail. These benchmarks highlight meaningful dispersion across Anthem, Aetna, BCBS, and Cigna.

    The CMS 2023 data represent national Medicare fee-for-service inpatient payments published under the CMS Provider Utilization and Payment Data program. The table below shows average total payment ($16.3k), average submitted covered charges ($56.6k), average Medicare payment ($13.1k), and total discharges (704).

    Average Total PaymentAverage Submitted ChargesAverage Medicare PaymentTotal Discharges
    $16K$57K$13K700

    Patient Population

    This DRG’s patient population is mixed but leans toward working-age adults under private/commercial coverage rather than exclusively Medicare-age beneficiaries. Medicare discharges are present (704 total in the CMS dataset) indicating a meaningful Medicare share, but commercial payers (Anthem, Aetna, BCBS, Cigna) also represent substantial utilization, reflecting a blend of payers across age groups.

    State Payment Rates

    State: Alaska1 / 49

    Alaska Benchmarks

    For DRG 883 payer-specific rates in Alaska span from $2.5K up to $54K across the included payers, reflecting substantial variability by insurer. Cigna posts the highest mean ($36K) and maximum ($54K), while Anthem and Blue Cross Blue Shield show the lowest reported minimums ($2.5K) and lower central tendencies (median $19K). These Alaska benchmarks deviate from national averages by exhibiting considerably higher top-end payments, as shown in the table and chart below.

    Key Insights for Alaska

    • Highest payer: Cigna (max $54K, mean $36K, median $31K) represents the top regional rates; lowest payer: Anthem/Blue Cross Blue Shield (both share identical benchmarks with min $2.5K, mean $22K, median $19K).
    • Alaska’s payer range is wide ($2.5K to $54K) and the state mean levels (Cigna mean $36K; Anthem/BCBS mean $22K) sit well above typical national medians for this DRG, indicating materially higher reimbursement at the upper end.

    Clinical Trials

    • Acute inpatient behavioral intervention trials: Studies testing time-limited, structured behavioral or psychotherapeutic interventions delivered during hospitalization for patients admitted with severe personality or impulse-control crises (for example, acute self-harm, suicidal ideation, or aggressive outbursts). These trials enroll adults with high-risk presentations requiring inpatient stabilization to assess short-term reduction in dangerous behaviors, need for restraint or seclusion, and safe disposition at discharge. Results are relevant to providers for optimizing in-hospital protocols and to payers because effective acute interventions can shorten length of stay and reduce use of high-intensity resources.
    • Comparative effectiveness studies of outpatient follow-up models after discharge: Research comparing different post-discharge care pathways such as intensive outpatient psychotherapy, community-based case management, or stepped-care coordination for patients discharged after inpatient stabilization for personality disorders or impulse-control disorders. These studies focus on real-world adult and sometimes adolescent populations at high risk for readmission, emergency visits, or recurrent self-harm, measuring outcomes like readmission rates, adherence to follow-up, and functional status. Findings inform clinicians and payers about which care transitions and service mixes best prevent costly readmissions and improve continuity of care.
    • Pragmatic trials of adjunctive therapies and service delivery in comorbid populations: Trials evaluating the addition of adjunctive interventions (for example, brief dialectical-behavior skills modules delivered by generalist staff, mobile health symptom monitoring, or family-involvement programs) in patients with personality or impulse-control disorders complicated by comorbid substance use, mood disorders, or medical conditions. These studies enroll heterogeneous inpatient and recently discharged cohorts to assess real-world effectiveness on impulse-related outcomes, treatment engagement, and downstream service utilization over months. The research matters to providers and payers because comorbidity drives complexity and costs; pragmatic evidence helps allocate resources toward scalable interventions that reduce long-term utilization and improve management across care settings.

    Related Codes

    876-O-R-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-OF-MENTAL-ILLNESS

    O.R. Procedures with Principal Diagnosis of Mental Illness: Inpatient Reimbursement Overview

    880-ACUTE-ADJUSTMENT-REACTION-AND-PSYCHOSOCIAL-DYSFUNCTION

    Acute Adjustment Reaction and Psychosocial Dysfunction: Inpatient Reimbursement Overview

    881-DEPRESSIVE-NEUROSES

    Depressive Neuroses: Inpatient Reimbursement Overview

    882-NEUROSES-EXCEPT-DEPRESSIVE

    Neuroses Except Depressive: Inpatient Reimbursement Overview

    884-ORGANIC-DISTURBANCES-AND-INTELLECTUAL-DISABILITY

    Organic Disturbances and Intellectual Disability: Inpatient Reimbursement Overview

    885-PSYCHOSES

    Psychoses: Inpatient Reimbursement Overview

    886-BEHAVIORAL-AND-DEVELOPMENTAL-DISORDERS

    Behavioral and Developmental Disorders: Inpatient Reimbursement Overview

    887-OTHER-MENTAL-DISORDER-DIAGNOSES

    Other Mental Disorder Diagnoses: Inpatient Reimbursement Overview

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Mean Rates by Payer — National — DRG 883
    Mean Rates by Payer — Alaska — DRG 883